1,205
Views
39
CrossRef citations to date
0
Altmetric
Review

Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials

, , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 555-564 | Received 13 Jun 2018, Accepted 29 Jun 2018, Published online: 13 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Muaawia Hamza, Muhanad Alhujaily, Bandar Alosaimi, Karim El Bakkouri, Mohammed S. AlDughaim, Mona Alonazi, Mona Awad Alanazi, Basma Abbass, Abdulsalam Alshehri, Samia T. Al-Shouli, Wael Alturaiki & Maaweya Awadalla. (2023) Association between inflammatory cytokines/chemokines, clinical laboratory parameters, disease severity and in-hospital mortality in critical and mild COVID-19 patients without comorbidities or immune-mediated diseases. Journal of Immunoassay and Immunochemistry 44:1, pages 13-30.
Read now
Yolanda Peña-López, Sergio Ramirez-Estrada, Vandana Kalwaje Eshwara & Jordi Rello. (2018) Limiting ventilator-associated complications in ICU intubated subjects: strategies to prevent ventilator-associated events and improve outcomes. Expert Review of Respiratory Medicine 12:12, pages 1037-1050.
Read now

Articles from other publishers (37)

Sedat Ozbay, Mustafa Ayan, Orhan Ozsoy, Canan Akman & Ozgur Karcioglu. (2023) Diagnostic and Prognostic Roles of Procalcitonin and Other Tools in Community-Acquired Pneumonia: A Narrative Review. Diagnostics 13:11, pages 1869.
Crossref
Philipp Schuetz. (2023) How to best use procalcitonin to diagnose infections and manage antibiotic treatment. Clinical Chemistry and Laboratory Medicine (CCLM) 61:5, pages 822-828.
Crossref
Monica Chwala, Faye Hartmann, Kenneth WallerIIIIII, Allison Dusick & Katrina Viviano. (2022) Change over time and agreement between clinical markers of disease resolution in dogs with aspiration‐induced lung injury. Veterinary Record 192:8.
Crossref
Marissa Z. Powell, Kristin C. Mara, Radhika Bansal, Matthew A. Hathcock, Arushi Khurana, N. Nora Bennani, Yucai Wang, Jonas Paludo, Jose Villasboas Bisneto, Stephen M. Ansell, Patrick B. Johnston, Yi Lin & Jason N. Barreto. (2023) Procalcitonin as a biomarker for predicting bacterial infection in chimeric antigen receptor T‐cell therapy recipients. Cancer Medicine 12:8, pages 9228-9235.
Crossref
Philipp Schuetz. 2023. Management of Dysregulated Immune Response in the Critically Ill. Management of Dysregulated Immune Response in the Critically Ill 145 150 .
Dhruva Chaudhry, Anita Sharma, Deepak Govil, Vijay Hadda, Neetu Jain, Pawan Tiwari, Srinivas Samavedam, Subhal Dixit, Manjunath B Govindagoudar, Gopi C Khilnani, Niraj Tyagi, Kapil Gangadhar Zirpe, Atul Prabhakar Kulkarni, Simant Kumar Jha, Subhash Kumar Todi & Madhusudan R Jaju. (2022) Guidelines for the Use of Procalcitonin for Rational Use of Antibiotics. Indian Journal of Critical Care Medicine 26:S2, pages S77-S94.
Crossref
Shena Y. C. Lim, Yvonne P. Zhou, Daphne Yii, De Zhi Chin, Kai Chee Hung, Lai Wei Lee, Jia Le Lim, Li Wen Loo, Narendran Koomanan, Nathalie Grace Chua, Yixin Liew, Benjamin P. Z. Cherng, Siew Yee Thien, Winnie H. L. Lee, Andrea L. H. Kwa & Shimin J. Chung. (2022) Stemming the Rise of Antibiotic Use for Community-Acquired Acute Respiratory Infections during COVID-19 Pandemic. Antibiotics 11:7, pages 846.
Crossref
Xin-Xin XU, Xian-Lu LEI, Li-Ya YE, Shan-Shan SONG, Li-Liang LIU, Li-Guang XU, Chuan-Lai XU & Hua KUANG. (2022) Gold‐based paper sensor for sensitive detection of procalcitonin in clinical samples. Chinese Journal of Analytical Chemistry 50:4, pages 100062.
Crossref
Bruna Carolina de Araújo, Roberta Crevelário de Melo, Maritsa Carla de Bortoli, José Ruben de Alcântara Bonfim & Tereza Setsuko Toma. (2022) Prevenção e controle de resistência aos antimicrobianos na Atenção Primária à Saúde: evidências para políticas. Ciência & Saúde Coletiva 27:1, pages 299-314.
Crossref
乐乐 曹. (2022) Research Progress of Serum, Cerebrospinal Fluid Procalcitonin and Neurosurgical Central Nervous System Infections. Advances in Clinical Medicine 12:10, pages 9024-9029.
Crossref
Nilüfer Aylin Acet Öztürk & Esra Uzaslan. 2022. ENT Diseases: Diagnosis and Treatment during Pregnancy and Lactation. ENT Diseases: Diagnosis and Treatment during Pregnancy and Lactation 773 783 .
Sizhe Hu, Xiaokang Zhao, Feng Qian, Cancan Jin & Kaishun Hou. (2021) Correlation between LRP1B Mutations and Tumor Mutation Burden in Gastric Cancer. Computational and Mathematical Methods in Medicine 2021, pages 1-6.
Crossref
Eva Heilmann, Claudia Gregoriano, Djillali Annane, Konrad Reinhart, Lila Bouadma, Michel Wolff, Jean Chastre, Charles-Edouard Luyt, Florence Tubach, Angela R Branche, Matthias Briel, Mirjam Christ-Crain, Tobias Welte, Caspar Corti, Evelien de Jong, Maarten Nijsten, Dylan W de Lange, Jos A H van Oers, Albertus Beishuizen, Armand R J Girbes, Rodrigo O Deliberato, Stefan Schroeder, Kristina B Kristoffersen, Nathalie Layios, Pierre Damas, Stella S S Lima, Vandack Nobre, Long Wei, Carolina F Oliveira, Yahya Shehabi, Daiana Stolz, Michael Tamm, Alessia Verduri, Jin-Xiang Wang, Sabine Drevet, Gaetan Gavazzi, Beat Mueller & Philipp Schuetz. (2021) Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trials. Age and Ageing 50:5, pages 1546-1556.
Crossref
Stefano Aliberti, Charles S Dela Cruz, Francesco Amati, Giovanni Sotgiu & Marcos I Restrepo. (2021) Community-acquired pneumonia. The Lancet 398:10303, pages 906-919.
Crossref
Valerio Nardone, Rocco Giannicola, Giovanna Bianco, Diana Giannarelli, Paolo Tini, Pierpaolo Pastina, Antonia Consuelo Falzea, Sebastiano Macheda, Michele Caraglia, Amalia Luce, Silvia Zappavigna, Luciano Mutti, Luigi Pirtoli, Antonio Giordano & Pierpaolo Correale. (2021) Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1/PD-L1 Immune-Checkpoint Blockade. Frontiers in Oncology 11.
Crossref
Sebastien De Ruffi, Marion Gornet, Laurent Ramont, Pierre Leroux, Guillaume Giordano Orsini, Xavier Losset, Lukshe Kanagaratnam & Stéphane Gennai. (2021) Analysis of 1635 procalcitonin prescriptions in the emergency department of a university hospital: A gap between evidence‐based medicine and the real world?. International Journal of Clinical Practice 75:6.
Crossref
Jiaqi Di, Xuanlin Li, Yang Xie, Shuguang Yang & Xueqing Yu. (2021) Procalcitonin‐guided antibiotic therapy in AECOPD patients: Overview of systematic reviews. The Clinical Respiratory Journal 15:6, pages 579-594.
Crossref
Wafa Sayah, Ismahane Berkane, Imène Guermache, Mohamed Sabri, Fatma Zahra Lakhal, Sarah Yasmine Rahali, Asma Djidjeli, Lydia Lamara mahammed, Fatma Merah, Brahim Belaid, Lilya Berkani, Nouzha Zhor Lazli, Lylia Kheddouci, Ahmed Kadi, Mourad Ouali, Rachida Khellafi, Dalila Mekideche, Assia Kheliouen, Réda Malek Hamidi, Soraya Ayoub, Nabil Beramtane Raaf, Fawzi Derrar, Merzak Gharnaout, Ines Allam & Réda Djidjik. (2021) Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19. Cytokine 141, pages 155428.
Crossref
Wen Song, Yue Wang, Fengming Tian, Liang Ge, Xiaoqian Shang, Qiang Zeng, Ning Feng, Jiahui Fan, Jing Wang & Xiumin Ma. (2021) Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Disease Markers 2021, pages 1-9.
Crossref
Lauren T. Clark, Thomas S. Beuschel, Paige M. Buss, Andrew P. Jameson & Lisa E. Dumkow. (2021) Comparison of procalcitonin testing to a targeted audit-and-feedback strategy on prescribed durations of therapy for community-acquired pneumonia. Diagnostic Microbiology and Infectious Disease 99:1, pages 115202.
Crossref
Ingrid Christensen, Jon Birger Haug, Dag Berild, Jørgen Vildershøj Bjørnholt & Lars-Petter Jelsness-Jørgensen. (2020) Hospital physicians’ experiences with procalcitonin – implications for antimicrobial stewardship; a qualitative study. BMC Infectious Diseases 20:1.
Crossref
Ahmed Algohar & Ali Alqerban. (2020) Levels of procalcitonin in saliva and peri-implant crevicular fluid in patients with peri-implant diseases and health. Archives of Oral Biology 120, pages 104931.
Crossref
Chien-Chang Lee, Andrea Lay Hoon Kwa, Anucha Apisarnthanarak, Jia-Yih Feng, Eric Howard Gluck, Akihiro Ito, Anis Karuniawati, Petrick Periyasamy, Busadee Pratumvinit, Jeetendra Sharma, Rontgene Solante, Subramanian Swaminathan, Niraj Tyagi, Dien Minh Vu, Kapil Zirpe & Philipp Schuetz. (2020) Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting. Clinical Chemistry and Laboratory Medicine (CCLM) 58:12, pages 1983-1991.
Crossref
Diana Borre-Naranjo, Amilkar Almanza-Hurtado, Guillermo Ortiz-Ruiz & Carmelo Dueñas-Castell. (2020) Procalcitonina en el paciente crítico: ¿herramienta diagnóstica, guía intervención o marcador pronóstico?. Acta Colombiana de Cuidado Intensivo 20:4, pages 253-260.
Crossref
Mariska T. Meijer, Fabrice Uhel, Olaf L. Cremer, Marcus J. Schultz & Tom van der Poll. (2020) Tenascin C Plasma Levels in Critically Ill Patients with or Without Sepsis: A Multicenter Observational Study. Shock 54:1, pages 62-69.
Crossref
Vladimir V. Kulabukhov, А.К. Shabanov, Irina V. Andreeva, Оlga U. Stetsiouk & V.А. Andreev. (2020) Biomarkers of infection in the optimization of antibacterial therapy: justified expectations. Clinical Microbiology and Antimicrobial Chemotherapy, pages 175-187.
Crossref
Inga Petruschke, Mathias W. Pletz & Jutta Bleidorn. (2019) Infektionen der oberen Atemwege. CME 16:12, pages 9-18.
Crossref
O. Neeser, A. Branche, B. Mueller & P. Schuetz. (2019) How to: implement procalcitonin testing in my practice. Clinical Microbiology and Infection 25:10, pages 1226-1230.
Crossref
Philipp Schuetz, Albertus Beishuizen, Michael Broyles, Ricard Ferrer, Gaetan Gavazzi, Eric Howard Gluck, Juan González del Castillo, Jens-Ulrik Jensen, Peter Laszlo Kanizsai, Andrea Lay Hoon Kwa, Stefan Krueger, Charles-Edouard Luyt, Michael Oppert, Mario Plebani, Sergey A. Shlyapnikov, Giulio Toccafondi, Jennifer Townsend, Tobias Welte & Kordo Saeed. (2019) Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clinical Chemistry and Laboratory Medicine (CCLM) 57:9, pages 1308-1318.
Crossref
Marc A Meier, Angela Branche, Olivia L Neeser, Yannick Wirz, Sebastian Haubitz, Lila Bouadma, Michel Wolff, Charles E Luyt, Jean Chastre, Florence Tubach, Mirjam Christ-Crain, Caspar Corti, Jens-Ulrik S Jensen, Rodrigo O Deliberato, Kristina B Kristoffersen, Pierre Damas, Vandack Nobre, Carolina F Oliveira, Yahya Shehabi, Daiana Stolz, Michael Tamm, Beat Mueller & Philipp Schuetz. (2019) Procalcitonin-guided Antibiotic Treatment in Patients With Positive Blood Cultures: A Patient-level Meta-analysis of Randomized Trials. Clinical Infectious Diseases 69:3, pages 388-396.
Crossref
Angela Branche, Olivia Neeser, Beat Mueller & Philipp Schuetz. (2019) Procalcitonin to guide antibiotic decision making. Current Opinion in Infectious Diseases 32:2, pages 130-135.
Crossref
Fabrício Torres de Carvalho, Roberto Rabello Filho, Lucas Bulgarelli, Ary Serpa Neto & Rodrigo Octavio Deliberato. (2019) Procalcitonin as a Diagnostic, Therapeutic, and Prognostic Tool: a Critical Review. Current Treatment Options in Infectious Diseases 11:1, pages 1-11.
Crossref
Mihaela S. Stefan, Meng-Shiou Shieh, Kerry A. Spitzer, Penelope S. Pekow, Jerry A. Krishnan, David H. Au & Peter K. Lindenauer. (2019) Association of Antibiotic Treatment With Outcomes in Patients Hospitalized for an Asthma Exacerbation Treated With Systemic Corticosteroids. JAMA Internal Medicine 179:3, pages 333.
Crossref
Daniel G. Wootton, Michael J. Cox, Gregory B. Gloor, David Litt, Katja Hoschler, Esther German, Joanne Court, Odiri Eneje, Lynne Keogan, Laura Macfarlane, Sarah Wilks, Peter J. Diggle, Mark Woodhead, Miriam F. Moffatt, William O. C. Cookson & Stephen B. Gordon. (2019) A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease. Scientific Reports 9:1.
Crossref
P. Schuetz, A. Beishuizen, M. Broyles, R. Ferrer, G. Gavazzi, E. H. Gluck, J. Castillo, J.-U. Jensen, P. L. Kanizsai, A. Lay Hoon Kwa, S. Krueger, C.-E. Luyt, M. Oppert, M. Plebani, S. A. Shlyapnikov, G. Toccafondi, J. Townsend, T. Welte & K. Saeed. (2019) Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Laboratornaya sluzhba 8:4, pages 46.
Crossref
P. Schuetz & A.R. Falsey. (2018) Procalcitonin in patients with fever: one approach does not fit all. Clinical Microbiology and Infection 24:12, pages 1229-1230.
Crossref
A. Brinkmann, A. C. Röhr, O. R. Frey, W. A. Krüger, T. Brenner, D. C. Richter, K.‑F. Bodmann, M. Kresken & B. Grabein. (2018) S2k-Leitlinie der PEG zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei ErwachsenenS2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults. Der Anaesthesist 67:12, pages 936-949.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.